학술논문
Mid-regional proadrenomedullin (MR-proADM), Creactive protein (CRP) and other biomarkers in the early identification of disease progression in patients with COVID-19 in the acute NHS setting.
Document Type
Article
Author
Source
Journal of Clinical Pathology; Jun2023, Vol. 76 Issue 6, p400-406, 8p
Subject
Language
ISSN
00219746